Ignite Creation Date:
2024-05-05 @ 11:35 PM
Last Modification Date:
2024-10-26 @ 10:35 AM
Study NCT ID:
NCT01360047
Status:
COMPLETED
Last Update Posted:
2012-11-14
First Post:
2011-05-24
Brief Title:
Association Between Low Dose Acetylsalicylic Acid ASA and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Death
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Association Between Low Dose Acetylsalicylic Acid ASA and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Heart Disease Death - Nested Case Control Analyses in a Cohort of First-time Users of Low Dose ASA for Secondary Prevention of Cerebrovascular and Cardiovascular Outcomes
Status:
COMPLETED
Status Verified Date:
2012-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to estimate the risk of myocardial infarction MIcoronary death associated with use of monotherapy low dose ASA single antiplatelet as well as concomitant use of monotherapy low dose ASA and proton pump inhibitors PPIs in first- time users of low dose ASA for secondary prevention using a UK primary care database
Detailed Description:
Number of Anticipated Subjects In case-control analysis 5000-10000
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None